Captor Therapeutics Spolka Akcyjna (WSE:CTX)
Poland flag Poland · Delayed Price · Currency is PLN
81.80
-1.00 (-1.21%)
Mar 3, 2026, 4:49 PM CET

WSE:CTX Ratios and Metrics

Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
458197460667742-
Market Cap Growth
85.24%-57.12%-31.04%-10.15%--
Enterprise Value
426154410583--
Last Close Price
82.8042.3099.00160.00179.80-
PS Ratio
60.4712.4634.8472.82186.20-
PB Ratio
13.763.066.646.925.98-
P/TBV Ratio
13.863.086.676.975.99-
EV/Sales Ratio
56.229.7331.0463.61--
Debt / Equity Ratio
0.120.090.060.070.07-12.40
Net Debt / Equity Ratio
-0.97-0.52-1.04-0.87-0.88-1.78
Net Debt / EBITDA Ratio
0.860.991.062.684.31-0.32
Net Debt / FCF Ratio
4.121.041.303.523.27-2.22
Asset Turnover
0.140.170.130.070.05-
Quick Ratio
4.133.873.307.517.920.62
Current Ratio
4.133.903.327.577.980.66
Return on Equity (ROE)
-109.47%-57.48%-85.28%-32.55%-52.88%-
Return on Assets (ROA)
-48.16%-26.36%-43.40%-18.69%-24.24%-
Return on Capital Employed (ROCE)
-118.90%-57.80%-103.50%-38.50%-25.80%-211.60%
Earnings Yield
-8.89%-19.48%-15.35%-5.38%-4.39%-
FCF Yield
-1.70%-16.38%-12.00%-3.57%-4.52%-
Buyback Yield / Dilution
-6.24%-0.30%-11.46%-0.97%-14.99%-
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.